Intranasal midazolam for seizure cessation in the community setting

Area of Science:

• Pediatric Neurology
• Emergency Medicine
• Pharmacology

Background:

• Seizures in children can necessitate urgent intervention.
• Current first-line treatments like intravenous diazepam require specific access.
• Alternative administration routes have limitations.

Purpose of the Study:

• To explore non-intravenous methods for stopping pediatric seizures in a clinical setting.
• To evaluate the efficacy and safety of intranasal midazolam for seizure cessation.

Main Methods:

• Review of existing evidence on drug administration routes for pediatric seizures.
• Focus on intranasal drug delivery systems.
• Assessment of midazolam's properties for rapid action.

Main Results:

• Intranasal drug administration is a rapid and effective route in children.
• Intranasal midazolam shows significant promise for seizure cessation.
• Established routes like intramuscular, rectal, and buccal have noted limitations.

Conclusions:

• Intranasal midazolam presents a viable alternative to intravenous medications for pediatric seizure control.
• Its favorable safety profile supports its use in both clinic and prehospital environments.
• This route offers a practical solution when intravenous access is challenging.